Skip to content

The Role of Probiotic in the treatment of diarrhea among children

The role of probiotic in the treatment of diarrhea in children

Status
Unknown
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024633
Enrollment
90
Registered
2020-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A09- Infectious gastroenteritis and colitis, unspecified

Interventions

Intervention1: Lactobacillus acidophilus (2 billions) Lactobacillus Bulgaricus (1 billions) Bifidobacterium bifidum (1 billions) Fructooligosaccharides (100mg): Each capsule contains: Lactobacillus ac

Sponsors

Renata Pharmaceutical Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Children age: from 1 month to 12 years ii. Patients with both sexes iii. Patients who will suffer from dehydrating acute watery diarrhea of less than 14 days iv. Patients with clinical signs and symptoms of â??someâ?? dehydration (Thirst or eagerness to drink, sunken eyes, dry mouth and tongue and loss of skin elasticity (WHO 2006) v. Children who will have capacity to take oral medications

Exclusion criteria

Exclusion criteria: i.Patients who will have a history of an episode of diarrhea within one month of the present illness to exclude recurrent and persistent diarrhea ii.Patients who will have severe dehydration iii.Patients will have severe malnutrition as defined by Waterlow classification iv.Patients who will have diarrhea associated with another systemic illness (e.g. septicemia, pneumonia, urinary tract infection, and otitis media v. Patients who will have known hypersensitivity reaction to probiotics vi. Patients who will receive any antibiotic therapy within 1 month prior to inclusion in study

Design outcomes

Primary

MeasureTime frame
Parameters: 1.Frewuency and consistency of stool 2. Sign of dehydration 3. Temperature This will be measured depending upon duration of diarrhea after intervention. Timepoint: Baseline (Day 0) to complete recovery

Secondary

MeasureTime frame
a. Stool samples will be processed for the detection of established enteric pathogens including bacteria, viruses, parasites and other gut microbiota using standard techniques. Timepoint: Day 0 and day 30;b. Blood samples will be analyzed for the measurement of immunoglobulin level.Timepoint: Day 0 and Day 30

Countries

Bangladesh

Contacts

Public ContactProfessor Dr Abu Syed Md Mosaddek

Uttara Adhunik Medical College

Drmosaddek1968@gmail.com01711483814

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026